Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | PARG | Q86W56 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10580325 | 0.79 | CYP3A4 (0.36) | MEN1KMT2ACYP1A2GLATSHR | |
| SCHEMBL11237324 | 0.73 | ALDH1A1 (0.33) | MEN1KMT2ACYP1A2GLATSHR | |
| SCHEMBL2034712 | 0.70 | TDP1 (0.36) | MEN1KMT2ACYP1A2GLATSHR | |
| SCHEMBL7517627 | 0.68 | GLA (0.32) | MEN1KMT2AGLATSHRKDM4E | |
| SCHEMBL15656314 | 0.67 | TP53 (0.33) | — | |
| SCHEMBL24347511 | 0.67 | ALDH1A1 (0.34) | MEN1KMT2ACYP1A2GLATSHR | |
| SCHEMBL25199901 | 0.67 | ALDH1A1 (0.34) | MEN1KMT2ACYP1A2GLATSHR | |
| SCHEMBL28897741 | 0.67 | ALDH1A1 (0.34) | MEN1KMT2ACYP1A2GLATSHR | |
| SCHEMBL15660148 | 0.63 | KCNH2 (0.35) | CYP1A2TSHRTDP1L3MBTL1HTT | |
| SCHEMBL20836050 | 0.62 | TSHR (0.36) | MEN1KMT2ACYP1A2GLATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3985773-A1 | ELECTROLYTE, ELECTROCHEMICAL DEVICE INCLUDING ELECTROLYTE, AND ELECTRONIC DEVICE | Ningde Amperex Technology Ltd. (CN) | 2022-04-20 | — | — | EP | disclosed |
| US-20220052382-A1 | ELECTROLYTE, AND ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE COMPRISING THE SAME | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220052382-A1 | ELECTROLYTE, AND ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE COMPRISING THE SAME | KCNH3, C1S, KCNH2 | MEN1 183/4885KMT2A 2365/4885CYP1A2 1043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.